The estimated Net Worth of Douglas C Bryant is at least $26.4 Миллион dollars as of 22 February 2021. Mr. Bryant owns over 5,000 units of QuidelOrtho stock worth over $22,236,944 and over the last 17 years he sold QDEL stock worth over $0. In addition, he makes $4,168,770 as President, Chief Executive Officer и Director at QuidelOrtho.
Douglas has made over 43 trades of the QuidelOrtho stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of QDEL stock worth $826,500 on 22 February 2021.
The largest trade he's ever made was exercising 377,744 units of QuidelOrtho stock on 20 November 2019 worth over $8,469,020. On average, Douglas trades about 14,671 units every 32 days since 2007. As of 22 February 2021 he still owns at least 495,807 units of QuidelOrtho stock.
You can see the complete history of Mr. Bryant stock trades at the bottom of the page.
Douglas C. Bryant serves as President, Chief Executive Officer, Director of Company. Prior to joining us, Mr. Bryant served as Executive Vice President and Chief Operating Officer at Luminex Corporation, managing its Bioscience Group, Luminex Molecular Diagnostics (Toronto), manufacturing, R&D, technical operations, and commercial operations. From 1983 to 2007, Mr. Bryant held various worldwide commercial operations positions with Abbott Laboratories including, among others: Vice President of Abbott Vascular for Asia/Japan, Vice President of Abbott Molecular Global Commercial Operations and Vice President of Abbott Diagnostics Global Commercial Operations. Earlier in his career with Abbott, Mr. Bryant was Vice President of Diagnostic Operations in Europe, the Middle East and Africa, and Vice President of Diagnostic Operations Asia Pacific. Mr. Bryant has over 30 years of industry experience in sales and marketing, product development, manufacturing and service and support in both the diagnostics and life sciences markets. Mr. Bryant holds a B.A. in Economics from the University of California at Davis.
As the President, Chief Executive Officer и Director of QuidelOrtho, the total compensation of Douglas Bryant at QuidelOrtho is $4,168,770. There are no executives at QuidelOrtho getting paid more.
Douglas Bryant is 62, he's been the President, Chief Executive Officer и Director of QuidelOrtho since 2009. There are 11 older and 17 younger executives at QuidelOrtho. The oldest executive at QuidelOrtho Corporation is Mary Polan, 76, who is the Independent Director.
Over the last 21 years, insiders at QuidelOrtho have traded over $509,235,797 worth of QuidelOrtho stock and bought 304,015 units worth $10,385,234 . The most active insiders traders include Jack W Schuler, Matthew Strobeck и Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of $1,246,606. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth $3,078,785.
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
QuidelOrtho executives and other stock owners filed with the SEC include: